Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review.
Echeverria-Esnal D, Martín-Ontiyuelo C, Navarrete-Rouco ME, Barcelo-Vidal J, Conde-Estévez D, Carballo N, De-Antonio Cuscó M, Ferrández O, Horcajada JP, Grau S. Echeverria-Esnal D, et al. Among authors: carballo n. Expert Rev Anti Infect Ther. 2022 Feb;20(2):179-197. doi: 10.1080/14787210.2021.1962292. Epub 2021 Aug 18. Expert Rev Anti Infect Ther. 2022. PMID: 34328373 Review.
Clinical experience of TB in patients treated with anti-TNF-α.
Arenas-Miras M, Sánchez-Martínez F, Jové-Caballé N, Villar-García J, López-Montesinos I, Grau S, Carballo N, Knobel-Freud H, Horcajada JP. Arenas-Miras M, et al. Among authors: carballo n. Int J Tuberc Lung Dis. 2021 Oct 1;25(10):866-868. doi: 10.5588/ijtld.21.0166. Int J Tuberc Lung Dis. 2021. PMID: 34615586 No abstract available.
Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Carballo N, Garcia-Alzórriz E, Ferrández O, Navarrete-Rouco ME, Durán-Jordà X, Pérez-García C, Monfort J, Cots F, Grau S. Carballo N, et al. Front Pharmacol. 2021 Nov 29;12:752879. doi: 10.3389/fphar.2021.752879. eCollection 2021. Front Pharmacol. 2021. PMID: 34912219 Free PMC article.
Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Carballo N, Garcia-Alzórriz E, Ferrández O, Navarrete-Rouco ME, Durán-Jordà X, Pérez-García C, Monfort J, Cots F, Grau S. Carballo N, et al. Front Pharmacol. 2022 Mar 7;13:867017. doi: 10.3389/fphar.2022.867017. eCollection 2022. Front Pharmacol. 2022. PMID: 35341215 Free PMC article.
Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic.
Barceló-Vidal J, Echeverría-Esnal D, Carballo N, De Antonio-Cuscó M, Fernández-Sala X, Navarrete-Rouco ME, Colominas-González E, Luque S, Fuster-Esteva M, Domingo L, Sala M, Duran X, Grau S, Ferrández O. Barceló-Vidal J, et al. Among authors: carballo n. Front Pharmacol. 2022 Nov 24;13:993158. doi: 10.3389/fphar.2022.993158. eCollection 2022. Front Pharmacol. 2022. PMID: 36506516 Free PMC article.
33 results